UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000028619
Receipt number R000032753
Scientific Title Evaluation research on nursing support algorithm for harmonization of social role and treatment of cancer survivor
Date of disclosure of the study information 2017/08/25
Last modified on 2022/08/16 15:28:48

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation research on nursing support algorithm for harmonization of social role and treatment of cancer survivor

Acronym

Evaluation of nursing support algorithm for harmony between social role and treatment

Scientific Title

Evaluation research on nursing support algorithm for harmonization of social role and treatment of cancer survivor

Scientific Title:Acronym

Evaluation of nursing support algorithm for harmony between social role and treatment

Region

Japan


Condition

Condition

Cancer patients undergoing external chemotherapy / radiotherapy, care provided nurse

Classification by specialty

Nursing Adult

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Nursing support by nurses involved in outpatient cancer treatment and support by nursing algorithms for harmonizing social roles and treatments (hereinafter referred to as "nursing algorithm support") are continuing social roles of patients,assistance of nurses/Behavior)is different

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Nurse: Evaluation of nursing support for social role to target and Patient data: thermometers and troublesome thermometers and turnover rates

Key secondary outcomes

* Improve recognition of social role support
* Improve the quality of outpatient nursing


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is considered as a block.

Blocking

YES

Concealment

Pseudo-randomization


Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Behavior,custom

Interventions/Control_1

Algorithm support / regular care
Supporters support and support nursing algorithms that harmonize social roles and treatments. These can help support the situation of the roles of families, workers and local communities and the side effect management by treatment smoothly. Meanwhile, in the control group, care normally undertaken is carried out. Each for two months from before treatment

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

Outpatient chemotherapy center
Nurse working in outpatient department and patients who receive chemotherapy treatment and radiation therapy from the first time and those who care

Key exclusion criteria

Patient: Person who can not express his / her intention, palliative radiotherapy practitioner
Nurse: Person who is difficult to respond to interview

Target sample size

120


Research contact person

Name of lead principal investigator

1st name Kiyoko
Middle name
Last name Kanda

Organization

Gunma University Graduate School of Health Sciences

Division name

Department of Nursing

Zip code

371-8514

Address

3-39-22,Showa-machi Maebashi Gunma

TEL

027-220-8929

Email

kkanda@gunma-u.ac.jp


Public contact

Name of contact person

1st name Kanda
Middle name
Last name Kiyoko

Organization

Gunma University Graduate School of Health Sciences

Division name

Department of Nursing

Zip code

371-8514

Address

3-39-22,Showa-machi Maebashi Gunma

TEL

027-220-8929

Homepage URL


Email

kkanda@gunma-u.ac.jp


Sponsor or person

Institute

Takasaki University of Health and Welfare

Institute

Department

Personal name



Funding Source

Organization

MEXT(Japan)

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

MEXT JSPS KAKENHI Grant-in-Aid


Other related organizations

Co-sponsor

Takasaki University of Health and Welfare,Department of Nursing
Gunma Prefectural College of Health Sciences, Department of Nursing

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Gunma University

Address

Gunma Showa machi, Maebashi-city3-39-15

Tel

0272208929

Email

kkanda@gunma-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

群馬大学医学部附属病院(群馬県)
日高病院(群馬県)、藤岡総合病院(群馬県)


Other administrative information

Date of disclosure of the study information

2017 Year 08 Month 25 Day


Related information

URL releasing protocol

Cancer Nursing: April 9, 2022 - Volume - Issue - 10.1097/NCC.0000000000001108 doi: 10.1097/NCC.00000

Publication of results

Published


Result

URL related to results and publications

Cancer Nursing: April 9, 2022 - Volume - Issue - 10.1097/NCC.0000000000001108 doi: 10.1097/NCC.00000

Number of participants that the trial has enrolled

108

Results

DIT scores in the intervention group were significantly lower than those in the control group.2 months later 20 participants had resigned from their employment or were on leave in the control group (37.0%); this was twice the number in the intervention group, confirming a significant difference. Logistic regression analysis showed that the odds ratio in the control group was 3.6 times than that of the intervention group.The ANI appears to have prevented resignations 2 months after implementation.

Results date posted

2022 Year 08 Month 16 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results

2022 Year 04 Month 09 Day

Baseline Characteristics

The ages of the participants in the control group ranged from 45 to 81 years(mean 62.6), and those in the intervention group ranged from 33 to 79 years (mean 61.0). The mean ages of the groups did not differ significantly. Participants in the intervention and control groups were selected to match cancer setting, stage, PS, and treatment at sampling and the results were also similar. There were no significant difference in attributes between groups prior to the intervention.

Participant flow

In total,149 patients were invited to participate in the study and received written and verbal explanations of the study. Of these, 130 agreed to participate in the study. Randomization was performed at each facility, with 66 participants assigned to standard nursing support (control group), and 64 to the ANI (intervention group) (Figure 1). Study participants agreed to participate for two months. However, certain participants did not complete the study period for the following reasons: 1) declined to participate after the second time (n=6), 2) declined due to strong side-effects (n=2:), treatment or hospital change (n=3), and hospitalization (n=1), and 3) declined further treatment (n=2). The reason for 2) declined due to strong side-effects was only the intervention group, but otherwise there was no difference between the two groups. Nine participants were excluded from the analysis due to inadequate data. Data from 54 participants in each group were analyzed.

Adverse events

Strong side effects of the drug (n=2:)

Outcome measures

(1) Distress and Impact Thermometer (DIT)
(2) The number of adverse events
(3) Presence/absence of social roles
(4) Changes in employment
(5) Interprofessional collaboration

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2017 Year 08 Month 04 Day

Date of IRB

2017 Year 08 Month 03 Day

Anticipated trial start date

2017 Year 08 Month 20 Day

Last follow-up date

2020 Year 03 Month 31 Day

Date of closure to data entry

2020 Year 03 Month 31 Day

Date trial data considered complete

2020 Year 06 Month 01 Day

Date analysis concluded

2020 Year 10 Month 01 Day


Other

Other related information



Management information

Registered date

2017 Year 08 Month 09 Day

Last modified on

2022 Year 08 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032753


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name